Results 81 to 90 of about 13,126,675 (165)
Immediate hypersensitivity reaction following liposomal amphotericin-B (AmBisome) infusion.
, 2016 Liposomal amphotericin-B (AmBisome) is now becoming first choice for the treatment of visceral leishmaniasis (kala-azar) patients due to high efficacy and less toxicity.
core +1 more source
LIPOSOMAL AMPHOTERICIN-B IN 3 LUNG-TRANSPLANT RECIPIENTS
, 1995 Background: Opportunistic fungal infections are an important cause of morbidity and mortality in solid organ transplant recipients. Conventional therapy with amphotericin B is often restricted by toxicity.
VANDERBIJ, W, MANNES, GPM
core +1 more source
Antifungal activity of caspofungin in experimental infective endocarditis caused by Candida albicans
Memorias do Instituto Oswaldo CruzBACKGROUND Infective endocarditis is a disease characterised by heart valve lesions, which exhibit extracellular matrix proteins that act as a physical barrier to prevent the passage of antimicrobial agents.
Gerardo Becerra Victorio +7 more
doaj +1 more source
Recurrent Candida albicans Ventriculitis Treated with Intraventricular Liposomal Amphotericin B
Case Reports in Infectious Diseases, 2015 Central nervous system (CNS) infection with Candida is rare but significant because of its high morbidity and mortality. When present, it is commonly seen among immunocompromised and hospitalized patients.
Demet Toprak +5 more
doaj +1 more source
Journal of Microbiology and Infectious Diseases, 2016 In this paper, we present a 69 years old diabetic patient with mucormycosis who was succesfully treated with liposomal amphotericin B (LAMB), posaconazole and deferasirox despite having no adequate surgery.
Uğur Onal +6 more
doaj +1 more source
Efficacy and Toxicity of Amphotericin B Liposomal and Lipid Formulations
, 1995 Objective: To review the efficacy and toxicity of amphotericin B liposomal and various lipid formulations with conventional amphotericin B desoxycholate. Data Sources: Pertinent literature was identified via a MEDLINE search.
Jay P Rho, Jennifer H Cupo
core +1 more source
Pharmacokinetics of liposomal amphotericin B in pleural fluid.
, 2010 We report the penetration of liposomal amphotericin B into the pleural fluid of a patient with pulmonary zygomycosis and empyema. The ratio of area under the concentration-versus-time curve in pleural fluid (AUC(pleural fluid)) to that in serum (AUC ...
Roy Chowdhuri, Sinchita +9 more
core +1 more source
Antimony to Cure Visceral Leishmaniasis Unresponsive to Liposomal Amphotericin B [PDF]
, 2016 International audienceWe report on 4 patients (1 immunocompetent, 3 immunosuppressed) in whom visceral leishmaniasis had become unresponsive to (or had relapsed after) treatment with appropriate doses of liposomal amphotericin B.
Fanny Lanternier +59 more
core +2 more sources
Transcriptional blood signatures for active and amphotericin B treated visceral leishmaniasis in India [PDF]
, 2019 Amphotericin B provides improved therapy for visceral leishmaniasis (VL) caused by Leishmania donovani, with single dose liposomal-encapsulated Ambisome providing the best cure rates.
Michaela Fakiola +23 more
core +1 more source
The direct costs of treating human visceral leishmaniasis in Brazil
Revista da Sociedade Brasileira de Medicina TropicalINTRODUCTION: The drugs available for visceral leishmaniasis (VL) treatment in Brazil have specific characteristics in terms of operability, effectiveness, toxicity, and cost.
Tália Santana Machado de Assis +6 more
doaj +1 more source